JamesCroweMD

Pediatric Infectious Disease • Nashville, TN

Professor, Pediatrics, Vanderbilt University School of Medicine

Join to view full profile

Dr. Crowe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Crowe's full profile

Already have an account?

Office
3601 21st Ave S
Nashville, TN 37232
Phone+1 615-322-3000

Summary

I am Professor of Pediatrics, Pathology, Microbiology and Immunology, Ann Scott Carell Chair, and Director of the Vanderbilt Vaccine Center. My laboratory has a broad portfolio of work in the area of human immunology and immune repertoires, with an aim to discovery of mechanisms important to development of new vaccines. We have worked in East and West Africa, and has research collaborations ongoing with investigators in Uganda, Democratic Republic of the Congo, Nigeria, Sri Lanka, Chile and other international sites. I am the Director of the Human Immunome Project, an ambitious effort to identify the sequence of all transcripts for adaptive immune receptors on the planet. I am an elected member of the National Academy of Medicine, and have been the recipient of a number of major investigator awards for research, including the Judson Daland Prize of the American Philosophical Society, the Oswald Avery Award of the IDSA, the E. Mead Johnson Award for Excellence in Pediatrics, the Outstanding Investigator Award of the American Federation for Medical Research, the Norman J. Siegel Award of the American Pediatric Society and the inaugural Merck Future Insight Prize. I am an elected Fellow of AAM, AAAS, ASCI and AAP, IDSA, APS and others.

Unraveling the Mystery of Immunity | Dr. James Crowe, Jr. | TEDxNashville

World pandemics of infection are occurring at an ever increasing pace - bird flu, SARS, MERS, chikungunya, Ebola, Zika viruses. Which is the bigger foe, the wor

Researchers characterize antibodies that block H5N1 influenza viral transmission

H5N1 avian influenza is a highly pathogenic virus that has been responsible for several outbreaks of bird flu in humans over the past decade.

Vanderbilt Researchers Develop Potential Treatment for Chikungunya

In late 2013 the Caribbean had its first case of the mosquito-bourne chikungunya virus. Vanderbilt researchers race for the cure.

Vanderbilt researchers Isolate Ebola-Fighting Human Antibodies for Possible Trea

Vanderbilt University researchers in Nashville have isolated Ebola-fighting human antibodies - the first of its kind - that could lead to a new treatment.

Education & Training

University of North Carolina HospitalsResidency, Pediatrics, 1987 - 1990
University of North Carolina at Chapel Hill School of MedicineClass of 1987
Davidson CollegeBS, Pre-Med, Magna Cum Laude, 1983

Certifications & Licensure

TN State Medical License 1995 - 2025
NC State Medical License 1989 - 1999
American Board of Pediatrics Pediatric Infectious Diseases

Awards, Honors, & Recognition

Future Insight Prize Merck KGaA, 2019
Distinguished Medical Alumnus Award UNC School of Medicine, Chapel Hill, NC, 2018
Stanley J. Korsmeyer Award American Society for Clinical Investigation, 2017
Samuel Rosenthal Prize for Excellence in Academic Pediatrics Samuel Rosenthal Foundation, 2017
John H. Exton Award for Research Leading to Innovative Biological Concepts Vanderbilt University Medical Center, 2016
Midsouth Regional Emmy Award 2012
Mentor of the Year Award Vanderbilt Postdoctoral Association, 2012
Norman J. Siegel New Member Outstanding Science Award American Pediatric Society, 2010
Chancellor's Research Award Vanderbilt University, 2007
Ernest W. Goodpasture Faculty Research Award Vanderbilt University Medical Center, 2007
F. Peter Guengerich Award for Mentoring Postdoctoral Fellows Vanderbilt University Medical Center, 2007
Outstanding Investigator Award American Federation for Medical Research, 2007
E. Mead Johnson Award for Excellence in Pediatric Research Society for Pediatric Research, 2006
America's Top Pediatricians Consumers Research Council, 2006
Teacher of the Year Award Vanderbilt University School of Medicine Interdisciplinary Graduate Program, 2005, 2008
Oswald Avery Award for Early Achievement Infectious Diseases Society of America, 2005
Judson Daland Prize for Outstanding Achievement in Patient-Oriented Clinical Research American Philosophical Society, 2002
Young Investigator Award Society for Pediatric Research, 2001
Young Investigator Award Pediatric Infectious Diseases Society, 2000
Turner Scholar Award Vanderbilt University, 1999
Dade MicroScan Young Investigator Award American Society for Microbiology, 1999
Basil O’Connor Scholar Research Award March of Dimes, 1998
Pfizer Faculty Scholar Pfizer, Inc, 1996
Edward Curnen Award UNC Pediatrics, 1990
Outstanding Pediatric Resident Wake Medical Center, 1990
Alpha Epsilon Delta Davidson College, 1983
Omicron Delta Kappa Davidson College, 1983
Phi Beta Kappa Davidson College, 1983
Edward Stuart Scholarship Davidson College, 1979
Join now to see all

Publications & Presentations

PubMed

2 citations
Blocking of ebolavirus spread through intercellular connections by an MPER-specific antibody depends on BST2/tetherin.
Rodrigo I Santos, Philipp A Ilinykh, Colette A Pietzsch, Adam J Ronk, Kai Huang
Cell Reports. 2023-10-31
1 citations
Development of a Kinetic ELISA and Reactive B Cell Frequency Assay to Detect Respiratory Syncytial Virus Pre-Fusion F Protein-Specific Immune Responses in Infants.
Stephanie L Rolsma, Sandra M Yoder, Rachel S Nargi, Eric Brady, Natalia Jimenez-Truque
Journal of the Pediatric Infectious Diseases Society. 2023-05-31
13 citations
Computationally Designed Cyclic Peptides Derived from an Antibody Loop Increase Breadth of Binding for Influenza Variants
Alexander M. Sevy, Iuliia M. Gilchuk, Benjamin P. Brown, Nina G. Bozhanova, Rachel S. Nargi
Structure. 2020-10-06

Journal Articles

Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis
Hotard AL, Lee S, Currier MG, Crowe JE Jr, Sakamoto K, Newcomb DC, Peebles RS Jr, Plemper RK, Moore ML, Journal of Virology, 1/1/2015
Mechanism of human antibody-mediated neutralization of Marburg virus
Flyak, AI, Ilinykh PA, Murin CD, Garron T, Shen X, Fusco ML, Hashiguchi T, Bornholdht ZA, Slaughter JC, Sapparapu G, Ksiazek TG, Ward AB, Ollmann Saphire E, Bukreyev A..., Cell, 1/1/2015
Structural basis for Marburg and Ebola virus cross-reactivity by a human survivor antibody
Hashiguchi T, Fusco ML, Bornholdht ZA, Lee JE, Murin CD, Flyak AI, Li S, Matsuoka R, Kohda D, Yanagi Y, Sanner M, Ward AB, Crowe JE Jr, Ollmann Saphire E, Cell, 1/1/2015
Extremely potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins
Fibriansah G, Tan JL, Smith SA, de Alwis R, Ng T-S, Kostyuchenk VA, Jadi RS, Petra Kukkaro P, de Silva AM, Crowe JE Jr, Lok S-M, Nature Communications, 1/1/2015
Influenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and replicate to wild-type levels in tissue culture or mice
Hooper KA, Crowe JE Jr, Bloom JD, Journal of Virology, 1/1/2015
Keitel WA, Jackson LA, Edupuganti S, Winokur P, Mulligan MJ, Thornburg NJ, Patel SM, Rouphael NG, Wanger N, Lai L, Bangaru S, McNeal MM, Bellamy AR, Hill HR, for the V..., Journal of Infectious Diseases, 1/1/2015
Redesigned PG9 variant monoclonal antibodies that exhibit enhanced HIV neutralizing potency and breadth
Willis JR, Sapparapu G, Moola S, Julien J-P, Singh V, King HG, Xia Y, Pickens JA, Labranche CC, Finn JS, Briney BS, Montefiori DC, Wilson IA, Meiler J, Crowe JE Jr, Journal of Clinical Investigation, 1/1/2015
Design of protein multi-specificity using an independent sequence search reduces the barrier to low energy sequences
Sevy AM, Jacobs TM, Crowe JE Jr, Meiler J, PLoS Computational Biology, 1/1/2015
CryoEM structure shows antibody neutralizes dengue virus serotype 2 by locking E protein dimers
Fibriansah G, Ibarra KD, Ng T-S, Smith SA, Tan JL, Lim X-N, Ooi JSG, Kostyuchenko VA, Wang J, de Silva AM, Harris E, Crowe JE Jr*, Lok S-M, Science, 1/1/2015
Spleen tyrosine kinase mediates elevated secretion of IL-1beta by primary human monocytes after antibody-enhanced dengue virus infection
Callaway JB, Smith SA, McKinnon KP, de Silva AM, Crowe JE Jr, Ting J.P.-Y, Journal of Biological Chemistry, 1/1/2015
Vaccine-elicited antibody that neutralizes influenza H5N1 and variants binds the receptor site and polymorphic sites
Winarski KL, Thornburg NJ, Yu Y, Sapparapu G, Crowe Jr JE, Spiller BW, Proceedings of the National Academy of Sciences USA, 1/1/2015
Broad and ultrapotent human monoclonal antibodies with therapeutic activity against chikungunya virus
Smith SA, Silva LA, Fox JM, Flyak AI, Kose N, Sapparapu G, Khomandiak S, Ashbrook AW, Kahle KM, Fong RH, Swayne S, Doranz BJ, McGee CE, Heise MT, Pal P, Brien JD, Aust..., Cell Host and Microbe, 1/1/2015
A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type specific neutralizing antibodies
Gallichotte EN, Widman DG, Yount BL, Wahala WM, Durbin A, Whitehead S, Sariol CA, Crowe JE Jr, de Silva AM, Baric RS, mBio, 1/1/2015
Protective monoclonal antibodies recognizing multiple arthritogenic alphaviruses bind a single epitope and inhibit both viral entry and egress
Fox JM, Long F, Edeling MA, Lin H, Duijl-Richter MKS, Fong RH, Smit JM Doranz BJ, Crowe JE Jr, Fremont DH, Rossmann MG, Diamond MS, Cell, 1/1/2015
Differential accessibility of a rotavirus VP6 epitope in trimers comprising Type I, II, or III channels as revealed by binding of a human rotavirus VP6-specific antibody
Aiyegbo MS, Eli IM, Spiller BW, Williams DR, Kim R, Lee DE, Liu T, Li S, Stewart PL, Crowe JE Jr, Journal of Virology, 1/1/2014
Proof of principle for epitope-focused vaccine design
Correia BE, John T. Bates JT, Loomis RJ, Baneyx G, Jardine JG, Rupert P, Carrico C, Correnti C, Kalyuzhniy O, Vittal V, Connell MJ, Stevens E, Schroeter A, Chen M, Mac..., Nature, 1/1/2014
A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface
Fibriansah G, Tan J, de Alwis R, Smith SA, Ng T-S, Kostyuchenko V, Ibarra K, Harris E, de Silva A, Crowe JE Jr, Lok S-M, EMBO Molecular Medicine, 1/1/2014
Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity
Messer WB, de Alwis R, Yount BL, Royal SR, Huynh JP, Smith SA, Crowe JE Jr, Doranz BJ, Kahle KM, Pfaff JM, White LJ, Sariol CA, de Silva AM, Baric RS, Proceedings of the National Academy of Sciences USA, 1/1/2014
Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the f...
Bates JT, Keefer CJ, Slaughter JC, Kulp DW, Schief WR, Crowe JE Jr, Virology, 1/1/2014
STAT4-deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus challenge but enhances the lung RSV-specific CD8+...
Dulek DE, Newcomb DC, Toki S, Goliniewska K, Cephus J, Reiss S, Bates JT, Crowe JE Jr, Boyd K, Moore ML, Zhou W, Peebles RS Jr, Journal of Virology, 1/1/2014
Tissue-specific expressed antibody variable gene repertoires
Briney BS, Willis JR, Finn JA, McKinney BA, Crowe JE Jr, PLoS One, 1/1/2014
Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functio...
Smith SA, de Alwis AR, Kose N, Jadi RS, de Silva AM, Crowe JE Jr, Journal of Virology, 1/1/2014
Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera
de Alwis AR, Williams KL, Schmid MA, Wang W, Smith S, Crowe JE Jr., Harris E, Bhumi P, de Silva AM, PLoS Pathogens, 1/1/2014
Use of human hybridoma technology to isolate human monoclonal antibodies
Smith S, Crowe JE Jr, Microbiology Spectrum, 1/1/2014
Committing the oldest sins in the newest kind of ways-Antibodies targeting the influenza virus type A hemagglutinin globular head
Krause JC, Crowe JE Jr, Microbiology Spectrum, 1/1/2014
Join now to see all

Books/Book Chapters

Red Book, 2015 Report of the Committee on Infectious Diseases
Chapter: Human Metapneumovirus
Crowe JE JrEditors: Kimberlin DK, Brady MT, Jackson MA, Long SS.American Academy of Pediatrics, Elk Grove Village, ILEdition 30th,2015
Antibodies for Infectious Diseases
Editors: Crowe JE Jr, Boraschi D, Rappuoli R.ASM Press, Washington, DC2015
Methods in Molecular Biology: Human Respiratory Syncytial Virus: Methods and Protocols
Chapter: Development of human monoclonal antibodies against respiratory syncytial virus using a high efficiency human hybridoma technique
Alvarado G, Crowe JE JrEditors: R.A. Tripp and P. Jorquera.Humana Press2015
Antibodies for Infectious Diseases
Chapter: Use of human hybridoma technology to isolate human monoclonal antibodies
Smith SA, Crowe JE JrEditors: Crowe JE Jr, Boraschi D, Rappuoli R.ASM PressEdition 1st,2015
Reference Module in Biomedical Sciences
Chapter: Human respiratory viruses
Crowe JE JrElsevier2014
Antibodies for Infectious Diseases
Chapter: Committing the oldest sins in the newest kind of ways---antibodies targeting the influenza virus type A hemagglutinin globular head
Krause JC, Crowe JE JrEditors: Crowe JE Jr, Boraschi D, Rappuoli R.ASM PressEdition 1st,2014
Viral Infections in Humans: Epidemiology and Control
Chapter: Respiratory syncytial virus and human metapneumovirus
Williams JV, Crowe JE JrEditors: Kaslow, Richard A., Stanberry, Lawrence R., Le Duc, James W..SpringerEdition 5th,2014
Blood and Marrow Transplantation Long Term Management: Prevention and Complications
Chapter: Exposure to family members: infections and recent live vaccinations
Engelhardt BG, Crowe JE JrEditors: Bipin Savani.John Wiley and SonsEdition 1st,2013
Red Book, 2012 Report of the Committee on Infectious Diseases
Chapter: Human Metapneumovirus
Crowe JE JrEditors: Pickering LK, Baker CJ, Long SS, McMillan JA.American Academy of Pediatrics, Elk Grove Village, ILEdition 29th,2012
The Biology of Paramyxoviruses
Chapter: Metapneumoviruses
Williams JV, Crowe JE JrEditors: Samal S.Horizon Scientific PressEdition 1st,2011
Nelson's Textbook of Pediatrics
Chapter: Respiratory syncytial virus
Crowe JE JrEditors: Kliegman RM, Stanton B, St. Geme J and Schor N.Edition 19th,2011
Infectious Diseases of the Fetus and Newborn Infant
Chapter: Prevention of fetal and early life infections through maternal-neonatal immunization
Page 489.0 - 515.0Crowe JE JrEditors: J Remington, JO Klein, CB Wilson, V. Nizet, B. Maldonado.Elsevier, PhiladelphiaEdition 7th,2011
Red Book, 2009 Report of the Committee on Infectious Diseases
Chapter: Human Metapneumovirus
Page 463.0 - 464.0Crowe JE JrEditors: Pickering LK, Baker CJ, Long SS, McMillan JA.American Academy of Pediatrics, Elk Grove Village, ILEdition 28th,2009
Encyclopedia of Molecular Mechanisms of Disease
Chapter: Croup
Crowe JE JrEditors: Lang F.Springer2008
Principles and Practice of Pediatric Infectious Diseases
Chapter: Respiratory syncytial virus
Williams JV, Crowe JE JrEditors: Long SS, Prober CG, Pickering LK.Churchill-Livingstone, New YorkEdition 3rd,2007
Encyclopedia of Virology
Chapter: Human respiratory viruses
Crowe JE JrEditors: Granoff A, Webster R.ElsevierEdition 3rd,2007
Principles and Practice of Pediatric Infectious Diseases
Chapter: Human metapneumovirus
Peters TR, Crowe JE JrEditors: Long SS, Prober CG, Pickering LK.Churchill-Livingstone, New York2007
Field's Virology
Chapter: Respiratory Syncytial Virus and Human Metapneumovirus
Page 1601. - 1646.Collins PL, Crowe JE JrEditors: Knipe, Howley, Griffin, Lamb, Martin, Roizman, and Straus.Lippincott, Williams, and Wilkins, BaltimoreEdition 5th,2007
Field's Virology
Chapter: Immunization against viral diseases
Page 487.0 - 538.0Graham BS, Crowe JE JrEditors: Knipe, Howley, Griffin, Lamb, Martin, Roizman, and Straus.Lippincott, Williams, and Wilkins, BaltimoreEdition 5th,2007
Nelson's Textbook of Pediatrics
Chapter: Human Metapneumovirus
Page 1391. - 1393.Crowe JE JrEdition 18th,2007
Manual of Clinical Microbiology
Chapter: Respiratory syncytial virus and human metapneumovirus
Page 1361. - 1377.Tang YW, Crowe JE JrEdition 9th,2007
Schaecter’s Mechanisms of Microbial Disease
Chapter: Paramyxoviruses: Measles, Mumps, and Respiratory Syncytial Virus
Page 347.0 - 356.0Williams JV, Crowe JE JrEditors: Engleberg, DiRita, Dermody.Lippincott, Williams, and Wilkins, BaltimoreEdition 4th,2007
Red Book, 2006 Report of the Committee on Infectious Diseases
Chapter: Human Metapneumovirus
Page 460.0 - 461.0Crowe JE JrEditors: Pickering LK, Baker CJ, Long SS, McMillan JA.American Academy of Pediatrics, Elk Grove Village, ILEdition 27th,2006
Kendig's Disorders of the Respiratory Tract in Children
Chapter: Viral pneumonias
Page 433.0 - 440.0Crowe JE JrEditors: Thomas Boat, Victor Chernick, Robert Wilmott, Andrew Bush.Saunders W. B. Co2005
Immunologic Disorders in Infants and Children
Chapter: Ontogeny of Immunity
Page 3.0 - 19.0Lawton AR, Crowe JE JrEditors: Stiehm, Ochs, Winkelstein.Edition 5th,2004
Join now to see all

Abstracts/Posters

NIH Think Tank “B cell Help - HIV Vaccines
Crowe JE Jr, Bethesda, MD, 1/21/2014
19th Conference on Retroviruses and Opportunistic Infections
Crowe JE Jr, Seattle, WA, 1/8./2012
Biology of Acute Respiratory Infection
Crowe JE Jr, Gordon Conference, Ventura, CA, 1/11/2012
Symposium on Immunologic Diseases and Basic Immunology
Crowe JE Jr, University of Alabama at Birmingham, Birmingham, AL, 1/9./2012
NIH/FDA 2012 Universal Influenza Vaccines Meeting
Crowe JE Jr, Bethesda, MD, 1/19/2012
Understanding Bottlenecks in the Discovery of New Therapies for RSV
Crowe JE Jr, Wellcome Trust experts meeting, London, UK, 1/10/2012
AIDS Vaccine
Crowe JE Jr, Boston, MA, 1/12/2012
8th Annual Respiratory Syncytial Virus Symposium
Crowe JE Jr, Sante Fe, NM, 1/27/2012
Cent Gardes: HIV Vaccine Conference: The B cell response to HIV and HIV vaccines: From broadly neutralizing to non-neutralizing antibodies
Crowe JE Jr, Veyrier du Lac, France, 1/5./2012
11th International Symposium on Double-Stranded RNA Viruses
Crowe JE Jr, San Juan, Puerto Rico, 1/27/2012
Epithelial Biology Center Symposium
Crowe JE Jr, Nashville, TN, 1/18/2013
NIAID National Institutes of Health Dengue Vaccine Initiative, International Vaccine Institute, Consultation on Dengue Vaccines
Crowe JE Jr, Rockville, MD, 1/26/2013
RSV Vaccines for the World
Crowe JE Jr, Porto, Portugal, 1/14/2013
Cold Spring Harbor course on Phage Display of Antibodies and Peptides
Crowe JE Jr, Cold Spring Harbor, NY, 1/13/2013
Keystone Symposium on Pathogenesis of Respiratory Viruses
Crowe JE Jr, Keystone, Colorado, 1/20/2014
Third Annual Symposium on Respiratory Virus Pathogenesis
Crowe JE Jr, Buenos Aires, Argentina, 1/15/2014
Frontiers in Science Symposium
Crowe JE Jr, Annual AMSPDC/PSDP meeting, San Diego, CA, 1/4./2011
Common Barriers in Vaccine Research and Development
Crowe JE Jr, NIAID and FDA workshop, Rockville, MD, 1/19/2014
Antibody Discovery
Crowe JE Jr, Prophylactic Options to Environmental and Contagious Threats (PROTECT) Program Meeting, Cambridge, MA, 1/28/2014
12th Global Experts' Meeting (GEM) on Respiratory Viruses
Crowe JE Jr, Athens, Greece, 1/22/2014
9th Respiratory Syncytial Virus Symposium
Crowe JE Jr, Stellenbosch, South Africa, 1/9./2014
Epidemics, Pandemics, and Outbreaks of Contagious Diseases
Crowe JE Jr, Third Annual Global Action Summit, Nashville, TN, 1/16/2014
U.S. Leadership on Ebola in West Africa and at Home
Crowe JE Jr, Center for Strategic and International Studies meeting, Nashville, TN, 1/21/2014
Keystone Symposium on Viral Immunity
Crowe JE Jr, Breckenridge, CO, 1/11/2015
17th International Conference on Emerging Infectious Diseases (EID) Meeting
Crowe JE Jr, Taipei, Taiwan, 1/26/2015
Join now to see all

Lectures

Influenza
San Diego, CA - 1/1/2012
Correlates of Protection against Disease Caused by Virus Infection
San Diego, CA - 1/1/2012
Neutralizing antibodies to viruses
Boston, MA - 1/1/2011
Vaccines
Boston, MA - 1/1/2004
Respiratory Viral Infection: Advances in epidemiology and pathobiology (moderator)
Chicago, IL - 1/1/2002
Pediatric Research Seminar
Mercy Children’s Hospital, Kansas City, MO - 1/26/2001
Pediatric Infectious Diseases Research Seminar
Children’s Hospital, Cincinnati, OH - 1/12/2001
The Jack Light Lecture
Cedars Sinai Medical Center/UCLA Pediatrics Program, Los Angeles, CA - 1/27/2007
Pathogenesis Affinity Seminar Series
The Scripps Research Institute, La Jolla, CA - 1/9./2007
Microbiology and Immunology Research Seminar
University of Texas Health Sciences Center at San Antonio - 1/8./2007
La Jolla Institute for Allergy and Immunology’s (LIAI) Seminar Series
1/23/2011
11th International Symposium on Rotavirus
Delhi, India - 1/3./2015
Join now to see all

Other

This Week in Virology
Crowe JE Jr, podcast
http://www.twiv.tv/2015/04/12/twiv-332/
1/1/2015
Children’s Health Crisis
Crowe JE Jr, Nashville Public Television
1/1/2012
Epitope mapping of neutralizing antibodies to pathogenic viruses: A critical tool for rational vaccine design and evaluation
Crowe JE Jr
1/9./2015

Press Mentions

VUMC in the News, July 5, 2022July 1st, 2022
Covid-19 Antibody Cocktail Trials Employ Varied Variant-Tracking Strategies, but Data Lag Expected Given Focus on Clinical OutcomesMay 19th, 2021
CDC Grants $61.7M to State for Vaccine EffortsApril 6th, 2021
Join now to see all

Professional Memberships

Infectious Disease Society of America - IDSA
Fellow
American Society of Microbiology
Fellow
American Society for Virology
Member
Society for Pediatric Research
Member
American Association of Immunologists
Member
American Society for Clinical Investigation
Fellow
Association of American Physicians
Fellow
American Pediatric Society
Fellow
American Association for the Advancement of Science
Fellow
American Academy of Microbiology
Fellow
International Society for Vaccines
Member
Society for Mucosal Immunology
Member
The Antibody Society
Member
International Society for Infectious Diseases
Member
Infectious Disease Society of America - IDSA
Fellow

Industry Relationships

Founder, IDBiologicsBiotech focused on antibody discovery2017 - Present
Scientific Advisory Board, Rensavir2015 - Present
Scientific Advisory Board, Melissa Vaccines, IncVaccine company2015 - Present
Scientific Advisory Board, GigaGenCompany focused on advanced technology using immune repertoires2015 - Present
Scientific Advisory Board, CompuVaxVaccine company focused on computationally designed vaccines2014 - Present
Scientific Advisory Board, PaxVaxVaccine company2014 - Present
Founder, Corbeau BiotechBiotech focused on human antibodies for infectious diseases2010 - 2016